Endocrine disruption has been recognized as a priority endpoint in safety evaluation of chemicals and consumer products.
Endocrine disruption has been recognized as a priority endpoint in safety evaluation of chemicals and consumer products. Endocrine disrupting compounds (EDCs) are being classified as substances of very high concern and regulations to restrict their use are being installed world-wide. EDC effects are hard to predict and are best tested using bioassays.
CALUX® methods Available for endocrine disruption screening
To avoid animal studies BDS has developed a range of assays that allow screening and safety assessment of chemicals and complex mixtures including consumer products in a rapid and cost-effective manner.
In vitro assays
SaferWorlbyDesign provides In vitro testing/assays on compounds and formulations for the cosmetics, pharma, medical device, chemical, and food industries.
Tests and Services
SaferWorldbyDesign integrates in silico and in vitro methods to develop standard and premium Integrated Approaches to Testing and Assessment (IATAs), including methods that support ingredient and formulation screening and testing, product design and the preparation of Regulatory Dossiers.
Tissues and Fluids
Human skin samples, offered in our shop, are collected from patients who have undergone cosmetic surgery. We also offer additional services.